NDPP – Potential game-changing programme to delay or stop onset of Type 2 diabetes

Guest Blog by Louise Ansari, Director of Prevention, Diabetes UK

Louise AnsariMost readers of 2020Health will be concerned about the rising tide of diabetes – some may even have heard that there is a new push on prevention. As Diabetes Week 2015 begins, here’s some more detail on the heralded National Diabetes Prevention Programme (NDPP), jointly being developed by NHS England, Public Health England and Diabetes UK

A few facts and figures first. It’s announced this week that 3.3 million people in the UK now have diagnosed diabetes – and another 590,000 people have undiagnosed Type 2 diabetes. It’s a staggering and shameful fact that someone is diagnosed every three minutes, especially when evidence exists that up to 80 per cent of cases of Type 2 diabetes are preventable, or at least onset can be delayed by up to five years.

More than 20,000 people with diabetes die before their time every year. The condition is a leading cause of preventable sight loss in people of working age and is a major contributor to kidney failure, heart attack, and stroke. As well as the human cost, diabetes accounts for around 10 per cent of the annual NHS budget – £10 billion a year.

Many whole-society measures are necessary, including reformulation of food and drink products to reduce sugar and fat, and a reduction in portion size. Whole population health could improve if such measures were taken systematically. But we know as well from five international randomised control trials that high risk people who go through a programme focussing on improving diet and exercise will significantly reduce their risk of getting Type 2 diabetes.

That’s where NDPP comes in. We will deliver at scale, an evidence based lifestyle change programme focused on lowering weight, increasing physical activity and improving the diet of those individuals identified as being at high risk of developing Type 2 diabetes.

The singular aim of the programme is to reduce people’s risk of developing Type 2 diabetes across England. This will improve the health of the nation whilst at the same time relieve the system of a major financial burden, both in reducing costs of day to day diabetes management, but also potentially reducing the much higher costs of managing complications such as limb amputation.

The NHS Health Check programme will provide a key referral route into the programme – many GPs already say they wished they had a programme to refer people onto once the Health Check shows them to be at high risk. There will also be other referral routes into the programme – all based around a NICE validated risk score, and pharmacists, GPs and community groups will all play a key role here. Often GPs will already have identified individuals at high risk and will have information on their systems enabling them to refer into the NDPP.

The NDPP is undertaking a review of existing diabetes prevention programmes to establish an evidence base of effective interventions, and this will be published later in the summer. We are currently working with seven local ‘demonstrator sites’ (Birmingham South and Central CCG, Bradford City CCG, Durham County Council, Herefordshire CCG/LA, Medway CCG/LA, Salford CCG/LA and Southwark Council and CCG) to learn practical lessons from delivery, testing and evaluation approaches.   The demonstrator sites will pilot new approaches and help co-design the service. We’re also setting up reference groups of experts to inform clinical design, and patients to inform the design from a user experience perspective. During 2015/16 we are hoping to target up to 10,000 people to participate in an intervention. Procurement planning is also underway for future national roll-out, as is planning for evaluation of the scheme, to provide the robust evidence of efficacy here that was shown in international trial

The NDPP has the potential to be a truly game-changing programme, reducing pressure on the system, helping people regain better health, and delay or stop a diagnosis of Type 2 diabetes, a progressive and ultimately severe condition

Diabetes UK home page

If you want to receive regular information on the NDPP please email diabetesprevention@phe.gov



About Julia Manning

Julia Manning is a social pioneer, writer, campaigner and commentator. Formerly a clinical optometrist specialising in diabetes and visual impairment, she is the founder and Director of 2020health, an independent, social enterprise Think Tank whose aim is to Make Health Personal and Social. 2020health has through research, events and campaigning influenced opinion and action in fields as diverse as bioethics, alcohol, emerging technologies, fraud, education, consumer technology and vaccination. In 2014, 2020health were founding partners of the Health Tech and You Awards with Axa PPP and the Design Museum. Since 2016, 2020health has increasingly focused on digital health and public health in the community. Julia is a Fellow of the RSA and now also a part-time PhD student at the UCL Interaction Centre, studying the use of digital technology for stress management in the workplace. Julia has shared 2020health's research widely in the media (BBC News, ITV, Channel 5 News, BBC 1′s The Big Questions & Victoria Derbyshire, BBC Radio 4 Today, PM and Woman's Hour, LBC) and has taken part in debates and contributed to BBC’s Newsnight, Panorama, You and Yours and ITV’s The Week.
This entry was posted in Diabetes, NHS, NHS England, Public Health and tagged , , , , , , , . Bookmark the permalink.

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s